The variant of H5N1 bird flu has been circulating in wild birds, but this is the first time it’s been detected in cattle.
Dusty Pixel photography/Getty Images/Moment RF
hide caption
toggle caption
Dusty Pixel photography/Getty Images/Moment RF
New Variant of H5N1 Bird Flu Detected in Dairy Cattle for First Time
A concerning discovery in dairy cattle has added a new dimension to the ongoing bird flu pandemic. Scientists have identified a variant of H5N1 bird flu, previously known only to circulate among wild birds and cause severe illness in humans, in dairy herds in Nevada. This marks the first time this specific variant has been detected in cattle.
Key Findings from the USDA
The U.S. Department of Agriculture has confirmed the presence of this D1.1 genotype in dairy cattle. Initial findings suggest that the virus hopped from wild birds to cattle, sparking a new outbreak that poses unique challenges.
Understanding the Genetic Shift
This new variant belongs to a different genetic lineage compared to the strain responsible for previous infections in dairy cattle. The earlier outbreak was linked to a spillover event from wild birds to cattle in the Texas Panhandle late last year. However, this latest detection indicates an independent transmission, highlighting the ongoing nature of potential spillovers from wildlife.
The Implications for Vigilance
Michael Worobey, an evolutionary biologist from the University of Arizona, explains the situation with a metaphor: “It shows that even if you get rid of one virus that’s established itself, another one can pop up like whack-a-mole.” This statement underscores the necessity for continuous monitoring and vigilance in public health strategies.
The discovery raises several questions. How long has this variant been circulating in cattle? Is it widespread? And what does this mean for human health?
Challenges Ahead for Vaccination and Control
This new strain could complicate efforts to eliminate bird flu from dairy cattle. Worobey suggests that the immunity built against earlier variants may not offer protection against the D1.1 genotype, necessitating modifications in the development of vaccines. This could make eradication more difficult and unpredictable.

